(Q51892224)

17 April 2018

title

Pharmacological characterization of social isolation-induced hyperactivity. (English)

1 reference

17 April 2018

1 reference

1 reference

4

1 reference

17 April 2018

author name string

Katrine Fabricius

1

1 reference

17 April 2018

Lone Helboe

2

1 reference

17 April 2018

Anders Fink-Jensen

3

1 reference

17 April 2018

Björn Steiniger-Brach

5

1 reference

17 April 2018

publication date

31 December 2010

1 reference

17 April 2018

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

17 April 2018

volume

215

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

257-266

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1007/s00213-010-2128-9

exact match

0 references

cites work

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

The disruption of prepulse inhibition by social isolation in the Wistar rat: how robust is the effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Novel-object place conditioning in adolescent and adult male and female rats: effects of social isolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Increased dopaminergic activity in socially isolated rats: an electrophysiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Stereological brain volume changes in post-weaned socially isolated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Effects of isolation-rearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Post-weaning handling attenuates isolation-rearing induced disruptions of prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Schizophrenia: a concise overview of incidence, prevalence, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Behavioural and neurochemical effects of early social deprivation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Oral administration of L-serine reduces the locomotor activity of socially isolated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2128-9

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

21 January 2018

1 reference

12 December 2020

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Neurobiology of schizophrenia

1 reference

12 December 2020

The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.

1 reference

12 December 2020

Effect of isolation-rearing on conditioned dopamine release in vivo in the nucleus accumbens of the rat.

1 reference

12 December 2020

Schizophrenia: a review.

1 reference

12 December 2020

Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome

1 reference

12 December 2020

Isolation rearing-induced disruption of prepulse inhibition: further evidence for fragility of the response.

1 reference

12 December 2020

Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

1 reference

12 December 2020

10.1007/S00213-010-2128-9

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

21193984

1 reference

17 April 2018